| Primary Identifier | MGI:6711345 | Allele Type | Endonuclease-mediated |
| Attribute String | Humanized sequence | Gene | Atp6v0a1 |
| Strain of Origin | ICR | Is Recombinase | false |
| Is Wild Type | false |
| molecularNote | CRISPR/Cas9 technology generated a GA to AG change in exon 19 resulting in an arginine to glutamine substitution at residue 741 (p.R741Q) which corresponds to the human variant identified in an individual with developmental and epileptic encephalopathy. |
